On April 23, 2010, a New Jersey jury found claims of a Pfizer patent covering the Protonix acid reflux drug (pantoprazole ) valid and infringed by Teva Pharmaceutical Industries.
See previous IPBiz post:
Wyeth undercuts Teva on Protonix
The original patent was to Swiss drugmaker Nycomed and was licensed to Wyeth, which is now owned by Pfizer.
No comments:
Post a Comment